Live
- 178 Drivers turned up on the first day for and Eye Check-up Camp hosted by the IRB Golconda Expressway
- A star beyond the screen celebrates another year of excellence
- Russell stunned with pole in Las Vegas, says 'Got to deep dive into why we’re so quick'
- BJP hijacked electoral machinery for securing victory in Maharashtra: Cong
- Guwahati to host Indian National Rally Sprint Championship on Sunday
- Priyanka will now be seen in Wayanad more often: Robert Vadra
- Cong won all 3 seats on basis of guarantees, development: Dy CM on K’taka bypolls
- Santosh Trophy: Odisha rout Chhattisgarh to make final rounds
- BJP hijacked electoral machinery for securing victory in Maharashtra: Cong
- Formula 1: Russell pips Sainz to take pole in Las Vegas GP
IIL sets up new SFF in Telangana State
Indian Immunologicals Ltd (IIL), a city-based biologicals company, Monday announced the ground-breaking of a new Sterile Filling Facility (SFF) at its manufacturing plant in Phase III of Genome Valley, in Ranga Reddy district, with an investment of Rs 75 crore.
Hyderabad: Indian Immunologicals Ltd (IIL), a city-based biologicals company, Monday announced the ground-breaking of a new Sterile Filling Facility (SFF) at its manufacturing plant in Phase III of Genome Valley, in Ranga Reddy district, with an investment of Rs 75 crore.
With this upcoming filling facility, the company expects to increase its capacity to supply lifesaving vaccines such as the Anti Rabies Vaccine (ARV) Abhayrab.
The new state-of-the-art facility expected to be ready later next year. The sterile filling facility is equipped with hi-end equipment from the world's best manufacturers, in line with the requirements of the nature of work handled at the plant, it said.
K Anand Kumar, Managing Director of IIL said the animal health and human health player has a long history of supplying vaccines critical to public health.
"We are constantly striving to make the vaccines affordable and accessible to reach the benefits of preventive healthcare to maximum number of people.
The expansion at Karkapatla plant is in line with our mission and will help meet the growing requirements of critical vaccines," he said.
